Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors

Pediatric and Developmental Pathology

Volumn 14, Issue 5, 2011, Pages 353-359

  Deisch, Jeremy ^a   Raisanen, Jack ^a   Rakheja, Dinesh ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

Author keywords

Atypical teratoid rhabdoid tumor; Central nervous system; Kidney; LIN28; Malignant rhabdoid tumor; SALL4

Indexed keywords

LIN28 PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PEPTIDES AND PROTEINS; SALL4 PROTEIN; TCL1 PROTEIN; TRANSCRIPTION FACTOR NANOG; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BRAIN CANCER; CENTRAL NERVOUS SYSTEM MALIGNANT RHABDOID TUMOR; CHILD; CLINICAL ARTICLE; EMBRYONIC STEM CELL; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; KIDNEY CANCER; KIDNEY MALIGNANT RHABDOID TUMOR; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DNA HELICASES; EMBRYONIC STEM CELLS; FEMALE; HUMANS; INFANT; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; RHABDOID TUMOR; RNA-BINDING PROTEINS; TERATOMA; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84855369481     PISSN: 10935266     EISSN: 16155742     Source Type: Journal    
DOI: 10.2350/10-09-0902-OA.1     Document Type: Article

References (46)

1. Shashi V, Lovell M, von Kap-herr C, Waldron P, Golden W. Malignant rhabdoid tumor of the kidney: involvement of chromosome 22. Genes Chromosomes Cancer 1994;10:49-54. (Pubitemid 24137268)
2. Versteege I, Sévenet N, Lange J, et al. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Nature 1998;394:203-206. (Pubitemid 28325977)
3. Gao X, Tate P, Hu P, Tjian R, Skarnes WC, Wang Z. ES cell pluripotency and germ-layer formation require the SWI/SNF chromatin remodeling component BAF250a. Proc Natl Acad Sci U S A 2008;105: 6656-6661. (Pubitemid 351754562)
4. Ho L, Jothi R, Ronan JL, Cui K, Zhao K, Crabtree GR. An embryonic stem cell chromatin remodeling complex, esBAF, is an essential component of the core pluripotency transcriptional network. Proc Natl Acad Sci U S A 2009;106:5187-5191.
5. Doan DN, Veal TM, Yan Z, Wang W, Jones SN, Imbalzano AN. Loss of the INI1 tumor suppressor does not impair the expression of multiple BRG1-dependent genes or the assembly of SWI/SNF enzymes. Oncogene 2004;23:3462-3473. (Pubitemid 38669836)
6. Kidder BL, Palmer S, Knott JG. SWI/SNF-Brg1 regulates self-renewal and occupies core pluripotency-related genes in embryonic stem cells. Stem Cells 2009;27:317-328.
7. Roberts CW, Orkin SH. The SWI/SNF complex-chromatin and cancer. Nat Rev Cancer 2004;4:133-142.
8. Workman JL, Kingston RE. Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu Rev Biochem 1998;67:545-579. (Pubitemid 28411138)
9. Wang X, Sansam CG, Thom CS, et al. Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex. Cancer Res 2009;69:8094-8101.
10. Eble JN, Sauter G, Epstein JI, Sesterhenn IA, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs, 1st ed. Lyon: IARC Press, 2004.
11. Beckwith J. Wilms' tumor and other renal tumors of childhood: a selective review from the National Wilms' Tumor Study Pathology Center. Hum Pathol 1983;14:481-492. (Pubitemid 13104267)
12. Haas J, Palmer N, Weinberg A, Beckwith J. Ultrastructure of malignant rhabdoid tumor of the kidney. A distinctive renal tumor of children. Hum Pathol 1981;12:646-657. (Pubitemid 11012867)
13. Fung C, Gonzalez-Crussi F, Yonan T, Martinez N. "Rhabdoid Wilms" tumor: an ultrastructural study. Arch Pathol Lab Med 1981; 105:521-523. (Pubitemid 11000119)
14. Raisanen J, Biegel J, Hatanpaa K, Judkins A, White C, Perry A. Chromosome 22q deletions in atypical teratoid/rhabdoid tumors in adults. Brain Pathol 2005;15:23-28. (Pubitemid 40224063)
15. Hoot A, Russo P, Judkins A, Perlman E, Biegel J. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Am J Surg Pathol 2004;28:1485-1491. (Pubitemid 39425515)
16. Judkins A, Mauger J, Ht A, Rorke L, Biegel J. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 2004;28:644-650. (Pubitemid 38579568)
17. White F, Dehner L, Belchis D, et al. Congenital disseminated malignant rhabdoid tumor: a distinct clinicopathologic entity demonstrating abnormalities of chromosome 22q11. Am J Surg Pathol 1999;23:249-256. (Pubitemid 29117558)
18. Sigauke E, Rakheja D, Maddox D, et al. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the CNS, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis. Mod Pathol 2006;19:717-725.
19. Ota S, Crabbe D, Tran T, Triche T, Shimada H. Malignant rhabdoid tumor. A study with two established cell lines. Cancer 1993;71: 2862-2872. (Pubitemid 23120069)
20. Rorke L, Packer R, Biegel J. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg 1996;85:56-65. (Pubitemid 26195038)
21. Takei H, Bhattacharjee M, Rivera A, Dancer Y, Powell S. New immunohistochemical markers in the evaluation of central nervous system tumors: a review of 7 selected adult and pediatric brain tumors. Arch Pathol Lab Med 2007;131:234-241.
22. Ma HI, Kao CL, Lee YY, et al. Differential expression profiling between atypical teratoid/rhabdoid and medulloblastoma tumor in vitro and in vivo using microarray analysis. Childs Nerv Syst 2010; 26:293-303.
23. Cao D, Guo S, Allan RW, Molberg KH, Peng Y. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol 2009;33:894-904.
24. Cao D, Humphrey PA, Allan RW. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors. Cancer 2009;115: 2640-2651.
25. Cao D, Li J, Guo CC, Allan RW, Humphrey PA. SALL4 is a novel diagnostic marker for testicular germ cell tumors. Am J Surg Pathol 2009;33:1065-1077.
26. Liu A, Cheng L, Du J, et al. Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors. Am J Surg Pathol 2010;34: 697-706.
27. Mei K, Liu A, Allan RW, et al. Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: a study of 77 cases. Mod Pathol 2009;22:1628-1636.
28. Wang F, Liu A, Peng Y, et al. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3. Am J Surg Pathol 2009;33:1529-1539.
29. Cheng L, Sung MT, Cossu-Rocca P, et al. OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol 2007;211:1-9. (Pubitemid 46092024)
30. Jones TD, Ulbright TM, Eble JN, Baldridge LA, Cheng L. OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol 2004;28:935-940. (Pubitemid 38856851)
31. Emerson RE, Ulbright TM. Intratubular germ cell neoplasia of the testis and its associated cancers: the use of novel biomarkers. Pathology 2010;42:344-355.
32. Hart AH, Hartley L, Parker K, et al. The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer 2005;104:2092-2098. (Pubitemid 41579954)
33. Lau SK, Weiss LM, Chu PG. TCL1 protein expression in testicular germ cell tumors. Am J Clin Pathol 2010;133:762-766.
34. Narducci MG, Fiorenza MT, Kang SM, et al. TCL1 participates in early embryonic development and is overexpressed in human seminomas. Proc Natl Acad Sci U S A 2002;99:11712-11717. (Pubitemid 34994464)
35. West JA, Viswanathan SR, Yabuuchi A, et al. A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature 2009;460:909-913.
36. Yang J, Chai L, Gao C, et al. SALL4 is a key regulator of survival and apoptosis in human leukemic cells. Blood 2008;112:805-813.
37. Zhang J, Tam WL, Tong GQ, et al. Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat Cell Biol 2006;8:1114-1123. (Pubitemid 44473607)
38. Yu J, Vodyanik M, Smuga-Otto K, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318:1917-1920.
39. Wang XQ, Ongkeko WM, Chen L, et al. Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway. Hepatology 2010;52:528-539.
40. Hu T, Liu S, Breiter DR, Wang F, Tang Y, Sun S. Octamer 4 small interfering RNA results in cancer stem cell-like cell apoptosis. Cancer Res 2008;68:6533-6540.
41. Qiu C, Ma Y, Wang J, Peng S, Huang Y. Lin28-mediated posttranscriptional regulation of Oct4 expression in human embryonic stem cells. Nucleic Acids Res 2010;38:1240-1248.
42. Western PS, van den Bergen JA, Miles DC, Sinclair AH. Male fetal germ cell differentiation involves complex repression of the regulatory network controlling pluripotency. FASEB J 2010;24: 3026-3035.
43. Lee SH, Appleby V, Jeyapalan JN, et al. Variable methylation of the imprinted gene, SNRPN, supports a relationship between intracranial germ cell tumours and neural stem cells. J Neurooncol 2011; 101:419-428.
44. Foster K, Wang Y, Zhou D, Wright C. Dependence on PI3K/Akt signaling for malignant rhabdoid tumor cell survival. Cancer Chemother Pharmacol 2009;63:783-791.
45. Nocentini S. Apoptotic response of malignant rhabdoid tumor cells. Cancer Cell Int 2003;3:11.
46. Oh JS, Kim JJ, Byun JY, Kim IA. Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras. Int J Radiat Oncol Biol Phys 2010;76:5-8.